Embecta Corp (FRA:JX7)
€ 11.6 -0.2 (-1.69%) Market Cap: 658.85 Mil Enterprise Value: 1.89 Bil PE Ratio: 10.28 PB Ratio: 0 GF Score: 26/100

Embecta Corp at RBC Capital Markets Global Healthcare Conference Transcript

May 16, 2023 / 07:05PM GMT
Release Date Price: €26 (-6.47%)
Shagun Singh
RBC Capital Markets - Analyst

We'll go ahead and get started. Welcome to the 2023 RBC Global Healthcare Conference. I'm Shagun Singh, senior medical device analyst here at RBC. And I'm very pleased to have Embecta here as the next company speaking at the conference. Joining us from the company are Dev Kurdikar, President and Chief Executive Officer; and we also have Pravesh Khandelwal, Vice President of Investor Relations. Thank you so much for being here today.

Dev Kurdikar
Embecta Corp. - President & CEO

Thank you, Shagun. Thank you for having us.

Questions & Answers

Shagun Singh
RBC Capital Markets - Analyst

Great. So maybe I thought we'll start with some big-picture questions. Embecta completed the spin from Becton Dickinson in April of this year, the one-year anniversary. What have been the biggest surprises, either positive or negative, over the past year or so?

Dev Kurdikar
Embecta Corp. - President & CEO

Yes, I mean, it's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot